A00061-2
antibody from Boster Biological Technology
Targeting: CCR5
CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- A00061-2 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-CCR5 Picoband™ Antibody
- Antibody type
- Polyclonal
- Description
- Rabbit IgG polyclonal antibody for CCR5 detection. Tested with WB, Direct ELISA in Human;Mouse;Rat.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references Chemokine CCL8 and its receptor CCR5 in the spinal cord are involved in visceral pain induced by experimental colitis in mice.
The significance for chronic rejection of cardiac allograft of regulated upon activation normal T-cell cytokine and its CCR5 receptor.
Blocking the CC chemokine receptor 5 pathway by antisense peptide nucleic acid prolongs islet allograft survival.
Lu Y, Jiang BC, Cao DL, Zhao LX, Zhang YL
Brain research bulletin 2017 Oct;135:170-178
Brain research bulletin 2017 Oct;135:170-178
The significance for chronic rejection of cardiac allograft of regulated upon activation normal T-cell cytokine and its CCR5 receptor.
Zhao H, Zhang Y, Song G, Zhao W, Bai X, Zhang J, Zhao X
Transplantation proceedings 2013 Mar;45(2):635-8
Transplantation proceedings 2013 Mar;45(2):635-8
Blocking the CC chemokine receptor 5 pathway by antisense peptide nucleic acid prolongs islet allograft survival.
Yang L, Liu YF, Wu G, Zhang JL, Wang FS, Fu DZ, Zhao GH, Li TM
Transplantation proceedings 2007 Jan-Feb;39(1):185-90
Transplantation proceedings 2007 Jan-Feb;39(1):185-90
No comments: Submit comment
No validations: Submit validation data